Vanguard Group’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $3.67B | Buy |
21,076,344
+1,140,524
| +6% | +$208M | 0.05% | 321 |
|
|
2025
Q3 | $2.87B | Buy |
19,935,820
+2,291,328
| +13% | +$281M | 0.04% | 380 |
|
|
2025
Q2 | $1.78B | Sell |
17,644,492
-623,630
| -3% | -$47.7M | 0.03% | 502 |
|
|
2025
Q1 | $1.39B | Buy |
18,268,122
+49,149
| +0.3% | +$3.76M | 0.03% | 551 |
|
|
2024
Q4 | $1.26B | Buy |
18,218,973
+1,075,796
| +6% | +$77.5M | 0.02% | 590 |
|
|
2024
Q3 | $1.25B | Buy |
17,143,177
+1,130,167
| +7% | +$83.4M | 0.02% | 591 |
|
|
2024
Q2 | $1.07B | Buy |
16,013,010
+1,503,775
| +10% | +$58.3M | 0.02% | 615 |
|
|
2024
Q1 | $394M | Buy |
14,509,235
+383,714
| +3% | +$10.7M | 0.01% | 1127 |
|
|
2023
Q4 | $438M | Sell |
14,125,521
-219,991
| -2% | -$5.7M | 0.01% | 1045 |
|
|
2023
Q3 | $362M | Buy |
14,345,512
+1,024,956
| +8% | +$23.4M | 0.01% | 1086 |
|
|
2023
Q2 | $281M | Sell |
13,320,556
-42,755
| -0.3% | -$811K | 0.01% | 1283 |
|
|
2023
Q1 | $228M | Buy |
13,363,311
+322,480
| +2% | +$6.27M | 0.01% | 1386 |
|
|
2022
Q4 | $261M | Buy |
13,040,831
+1,686,861
| +15% | +$32.6M | 0.01% | 1281 |
|
|
2022
Q3 | $245M | Buy |
11,353,970
+106,326
| +0.9% | +$2.55M | 0.01% | 1270 |
|
|
2022
Q2 | $222M | Buy |
11,247,644
+148,938
| +1% | +$3.12M | 0.01% | 1353 |
|
|
2022
Q1 | $261M | Sell |
11,098,706
-21,724
| -0.2% | -$505K | 0.01% | 1376 |
|
|
2021
Q4 | $303M | Buy |
11,120,430
+287,229
| +3% | +$8.21M | 0.01% | 1348 |
|
|
2021
Q3 | $298M | Buy |
10,833,201
+186,495
| +2% | +$4.89M | 0.01% | 1329 |
|
|
2021
Q2 | $303M | Buy |
10,646,706
+961,181
| +10% | +$28.5M | 0.01% | 1341 |
|
|
2021
Q1 | $330M | Buy |
9,685,525
+322,398
| +3% | +$12.3M | 0.01% | 1245 |
|
|
2020
Q4 | $312M | Buy |
9,363,127
+198,200
| +2% | +$7.24M | 0.01% | 1172 |
|
|
2020
Q3 | $295M | Sell |
9,164,927
-231,822
| -2% | -$6.66M | 0.01% | 1026 |
|
|
2020
Q2 | $259M | Buy |
9,396,749
+959,588
| +11% | +$22.7M | 0.01% | 1106 |
|
|
2020
Q1 | $135M | Buy |
8,437,161
+261,085
| +3% | +$6.19M | 0.01% | 1353 |
|
|
2019
Q4 | $195M | Buy |
8,176,076
+2,467
| +0% | +$50.2K | 0.01% | 1403 |
|
|
2019
Q3 | $144M | Buy |
8,173,609
+193,672
| +2% | +$3.74M | 0.01% | 1534 |
|
|
2019
Q2 | $204M | Buy |
7,979,937
+896,047
| +13% | +$25M | 0.01% | 1345 |
|
|
2019
Q1 | $206M | Buy |
7,083,890
+134,506
| +2% | +$3.49M | 0.01% | 1322 |
|
|
2018
Q4 | $91.2M | Buy |
6,949,384
+146,678
| +2% | +$2.34M | ﹤0.01% | 1723 |
|
|
2018
Q3 | $138M | Buy |
6,802,706
+154,130
| +2% | +$3.48M | 0.01% | 1631 |
|
|
2018
Q2 | $157M | Buy |
6,648,576
+220,287
| +3% | +$5.67M | 0.01% | 1513 |
|
|
2018
Q1 | $145M | Buy |
6,428,289
+122,794
| +2% | +$3.23M | 0.01% | 1502 |
|
|
2017
Q4 | $197M | Buy |
6,305,495
+1,638,833
| +35% | +$48.4M | 0.01% | 1313 |
|
|
2017
Q3 | $146M | Buy |
4,666,662
+838,781
| +22% | +$16M | 0.01% | 1482 |
|
|
2017
Q2 | $65.7M | Buy |
3,827,881
+46,398
| +1% | +$792K | ﹤0.01% | 1884 |
|
|
2017
Q1 | $66.2M | Buy |
3,781,483
+173,532
| +5% | +$2.68M | ﹤0.01% | 1867 |
|
|
2016
Q4 | $47.7M | Buy |
3,607,951
+123,394
| +4% | +$1.68M | ﹤0.01% | 2006 |
|
|
2016
Q3 | $50.6M | Buy |
3,484,557
+72,824
| +2% | +$912K | ﹤0.01% | 1927 |
|
|
2016
Q2 | $33.6M | Buy |
3,411,733
+157,786
| +5% | +$1.84M | ﹤0.01% | 2079 |
|
|
2016
Q1 | $41.2M | Buy |
3,253,947
+48,583
| +2% | +$639K | ﹤0.01% | 1956 |
|
|
2015
Q4 | $58.2M | Buy |
3,205,364
+254,657
| +9% | +$4.49M | ﹤0.01% | 1806 |
|
|
2015
Q3 | $54.8M | Buy |
2,950,707
+1,010,487
| +52% | +$25.2M | ﹤0.01% | 1812 |
|
|
2015
Q2 | $47.4M | Buy |
1,940,220
+374,487
| +24% | +$8.5M | ﹤0.01% | 1972 |
|
|
2015
Q1 | $32.6M | Buy |
1,565,733
+238,500
| +18% | +$4.2M | ﹤0.01% | 2124 |
|
|
2014
Q4 | $20.5M | Buy |
1,327,233
+141,491
| +12% | +$2.01M | ﹤0.01% | 2227 |
|
|
2014
Q3 | $15.5M | Buy |
1,185,742
+192,697
| +19% | +$2.91M | ﹤0.01% | 2295 |
|
|
2014
Q2 | $19.8M | Buy |
993,045
+53,391
| +6% | +$791K | ﹤0.01% | 2222 |
|
|
2014
Q1 | $17.9M | Buy |
939,654
+85,049
| +10% | +$1.62M | ﹤0.01% | 2235 |
|
|
2013
Q4 | $14.5M | Buy |
854,605
+70,167
| +9% | +$1.07M | ﹤0.01% | 2299 |
|
|
2013
Q3 | $12.2M | Buy |
784,438
+121,228
| +18% | +$1.54M | ﹤0.01% | 2302 |
|
|
2013
Q2 | $7.93M | Buy |
+663,210
| New | +$6.78M | ﹤0.01% | 2441 |
|
Other funds holding INSM
DGM
BBA
RI
Vanguard Group's INSM Position: Q4 2025 in Review
Vanguard Group increased its Insmed (INSM) stake by 5.7% in Q4 2025, buying an estimated $208M and bringing the position to 21,076,344 shares worth $3.67B. The position accounts for 0.05% of the portfolio, ranked #321.
Vanguard Group first reported a position in INSM in Q2 2013 and has held it in 51 quarters since. 676 funds tracked by Wall St. Rank hold INSM as of Q4 2025.
- Vanguard Group held 21,076,344 shares of Insmed worth $3.67B as of Q4 2025.
- Vanguard Group bought 1,140,524 Insmed shares in Q4 2025, an estimated $208M.
- Insmed made up 0.05% of Vanguard Group's portfolio in Q4 2025, its #321 holding.
- Vanguard Group first reported a position in Insmed in Q2 2013 and has held it in 51 quarters since.
- 676 funds tracked by Wall St. Rank held Insmed as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.